Your browser doesn't support javascript.
loading
Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
Chitadze, Guranda; Stengel, Anna; John-Klaua, Cathrin; Bruckmüller, Julien; Trautmann, Heiko; Kotrova, Michaela; Darzentas, Franziska; Kelm, Miriam; Pal, Karol; Darzentas, Nikos; Bastian, Lorenz; Kehden, Britta; Wessels, Wiebke; Ströh, Aeint-Steffen; Oberg, Hans-Heinrich; Altrock, Philipp M; Baer, Constance; Meggendorfer, Manja; Gökbuget, Nicola; Baldus, Claudia D; Haferlach, Claudia; Brüggemann, Monika.
Afiliación
  • Chitadze G; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Stengel A; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.
  • John-Klaua C; Clinical Research Unit CATCH-ALL, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Bruckmüller J; Munich Leukemia Laboratory, Munich, Germany.
  • Trautmann H; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kotrova M; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Darzentas F; Solana Research GmbH, Windeby, Germany.
  • Kelm M; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Pal K; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Darzentas N; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Bastian L; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Kehden B; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Wessels W; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Ströh AS; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Oberg HH; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Altrock PM; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Baer C; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Meggendorfer M; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Gökbuget N; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Baldus CD; Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Haferlach C; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Brüggemann M; Clinical Research Unit CATCH-ALL, Christian-Albrechts-University of Kiel, Kiel, Germany.
Blood ; 141(13): 1640-1644, 2023 03 30.
Article en En | MEDLINE | ID: mdl-36450137

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Alemania